Journal Article
. 2011 Jun;3(8).
doi: 10.1002/emmm.201100150.

Combined genomic and phenotype screening reveals secretory factor SPINK1 as an invasion and survival factor associated with patient prognosis in breast cancer

Wendy Weijia Soon 1 Lance David Miller  Michael A Black  Cyril Dalmasso  Xiu Bin Chan  Brendan Pang  Chee Wee Ong  Manuel Salto-Tellez  Kartiki V Desai  Edison T Liu  
  • PMID: 21656687
  •     45 References
  •     19 citations


Secretory factors that drive cancer progression are attractive immunotherapeutic targets. We used a whole-genome data-mining approach on multiple cohorts of breast tumours annotated for clinical outcomes to discover such factors. We identified Serine protease inhibitor Kazal-type 1 (SPINK1) to be associated with poor survival in estrogen receptor-positive (ER+) cases. Immunohistochemistry showed that SPINK1 was absent in normal breast, present in early and advanced tumours, and its expression correlated with poor survival in ER+ tumours. In ER- cases, the prognostic effect did not reach statistical significance. Forced expression and/or exposure to recombinant SPINK1 induced invasiveness without affecting cell proliferation. However, down-regulation of SPINK1 resulted in cell death. Further, SPINK1 overexpressing cells were resistant to drug-induced apoptosis due to reduced caspase-3 levels and high expression of Bcl2 and phospho-Bcl2 proteins. Intriguingly, these anti-apoptotic effects of SPINK1 were abrogated by mutations of its protease inhibition domain. Thus, SPINK1 affects multiple aggressive properties in breast cancer: survival, invasiveness and chemoresistance. Because SPINK1 effects are abrogated by neutralizing antibodies, we suggest that SPINK1 is a viable potential therapeutic target in breast cancer.

Gene expression profiling spares early breast cancer patients from adjuvant therapy: derived and validated in two population-based cohorts.
Yudi Pawitan, Judith Bjöhle, +17 authors, Jonas Bergh.
Breast Cancer Res, 2005 Nov 11; 7(6). PMID: 16280042    Free PMC article.
Highly Cited.
Tissue microarrays characterise the clinical significance of a VEGF-A protein expression signature in gastrointestinal stromal tumours.
M Salto-Tellez, M E Nga, +8 authors, R Soong.
Br J Cancer, 2007 Feb 15; 96(5). PMID: 17299397    Free PMC article.
Lung metastasis genes couple breast tumor size and metastatic spread.
Andy J Minn, Gaorav P Gupta, +10 authors, Joan Massagué.
Proc Natl Acad Sci U S A, 2007 Apr 11; 104(16). PMID: 17420468    Free PMC article.
Highly Cited.
Cross talk between apoptosis and autophagy by caspase-mediated cleavage of Beclin 1.
M Djavaheri-Mergny, M C Maiuri, G Kroemer.
Oncogene, 2010 Jan 27; 29(12). PMID: 20101204
Highly Cited. Review.
Strong time dependence of the 76-gene prognostic signature for node-negative breast cancer patients in the TRANSBIG multicenter independent validation series.
Christine Desmedt, Fanny Piette, +18 authors, TRANSBIG Consortium.
Clin Cancer Res, 2007 Jun 05; 13(11). PMID: 17545524
Highly Cited.
Tumor-associated trypsin inhibitor as a prognostic factor during follow-up of bladder cancer.
Eija Kelloniemi, Erkki Rintala, +2 authors, Finnbladder Group.
Urology, 2003 Aug 02; 62(2). PMID: 12893328
Targeting apoptosis pathways in cancer therapy.
Irene M Ghobrial, Thomas E Witzig, Alex A Adjei.
CA Cancer J Clin, 2005 May 14; 55(3). PMID: 15890640
Highly Cited. Review.
Nuclear trafficking of secreted factors and cell-surface receptors: new pathways to regulate cell proliferation and differentiation, and involvement in cancers.
Nathalie Planque.
Cell Commun Signal, 2006 Oct 20; 4. PMID: 17049074    Free PMC article.
Why target apoptosis in cancer treatment?
Shailaja Kasibhatla, Ben Tseng.
Mol Cancer Ther, 2003 Jun 19; 2(6). PMID: 12813137
The humoral immune system has a key prognostic impact in node-negative breast cancer.
Marcus Schmidt, Daniel Böhm, +7 authors, Mathias Gehrmann.
Cancer Res, 2008 Jul 03; 68(13). PMID: 18593943
Highly Cited.
Apoptosis as a novel target for cancer chemoprevention.
Shi-Yong Sun, Numsen Hail, Reuben Lotan.
J Natl Cancer Inst, 2004 May 06; 96(9). PMID: 15126603
Highly Cited. Review.
Molecular portraits of human breast tumours.
C M Perou, T Sørlie, +15 authors, D Botstein.
Nature, 2000 Aug 30; 406(6797). PMID: 10963602
Highly Cited.
Genomic and transcriptional aberrations linked to breast cancer pathophysiologies.
Koei Chin, Sandy DeVries, +21 authors, Joe W Gray.
Cancer Cell, 2006 Dec 13; 10(6). PMID: 17157792
Highly Cited.
Aging impacts transcriptomes but not genomes of hormone-dependent breast cancers.
Christina Yau, Vita Fedele, +11 authors, Christopher C Benz.
Breast Cancer Res, 2007 Sep 14; 9(5). PMID: 17850661    Free PMC article.
An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival.
Lance D Miller, Johanna Smeds, +8 authors, Jonas Bergh.
Proc Natl Acad Sci U S A, 2005 Sep 06; 102(38). PMID: 16141321    Free PMC article.
Highly Cited.
Hepatitis B and hepatitis C virus replication upregulates serine protease inhibitor Kazal, resulting in cellular resistance to serine protease-dependent apoptosis.
Jason Lamontagne, Mark Pinkerton, Timothy M Block, Xuanyong Lu.
J Virol, 2009 Oct 30; 84(2). PMID: 19864383    Free PMC article.
Tropical calcific pancreatitis and its association with CTRC and SPINK1 (p.N34S) variants.
Monique H M Derikx, Richard Szmola, +3 authors, Joost P H Drenth.
Eur J Gastroenterol Hepatol, 2009 May 01; 21(8). PMID: 19404200
Urinary levels of tumor-associated trypsin inhibitor (TATI) in the detection of transitional cell carcinoma of the urinary bladder.
Shahrokh F Shariat, Michael P Herman, +3 authors, Ulf-Håkan Stenman.
Eur Urol, 2005 Jun 21; 48(3). PMID: 15963628
Translating insights from the cancer genome into clinical practice.
Lynda Chin, Joe W Gray.
Nature, 2008 Apr 04; 452(7187). PMID: 18385729    Free PMC article.
Highly Cited. Review.
Tumor-associated protein SPIK/TATI suppresses serine protease dependent cell apoptosis.
Xuanyong Lu, Jason Lamontagne, Felix Lu, Timothy M Block.
Apoptosis, 2008 Mar 19; 13(4). PMID: 18347987
High tissue expression of tumour-associated trypsin inhibitor (TATI) associates with a more favourable prognosis in gastric cancer.
J-P Wiksten, J Lundin, +3 authors, C Haglund.
Histopathology, 2005 Apr 07; 46(4). PMID: 15810949
Computer-assisted pathological immunohistochemistry scoring is more time-effective than conventional scoring, but provides no analytical advantage.
Chee Wee Ong, Lay Gek Kim, +6 authors, Manuel Salto-Tellez.
Histopathology, 2010 May 13; 56(4). PMID: 20459559
The molecular portraits of breast tumors are conserved across microarray platforms.
Zhiyuan Hu, Cheng Fan, +28 authors, Charles M Perou.
BMC Genomics, 2006 Apr 29; 7. PMID: 16643655    Free PMC article.
Highly Cited.
Autocrine induction of invasion and metastasis by tumor-associated trypsin inhibitor in human colon cancer cells.
V Gouyer, D Fontaine, +12 authors, G Huet.
Oncogene, 2008 Mar 05; 27(29). PMID: 18317448
Bioconductor: open software development for computational biology and bioinformatics.
Robert C Gentleman, Vincent J Carey, +22 authors, Jianhua Zhang.
Genome Biol, 2004 Oct 06; 5(10). PMID: 15461798    Free PMC article.
Highly Cited.
Predicting prognosis using molecular profiling in estrogen receptor-positive breast cancer treated with tamoxifen.
Sherene Loi, Benjamin Haibe-Kains, +16 authors, Christos Sotiriou.
BMC Genomics, 2008 May 24; 9. PMID: 18498629    Free PMC article.
Highly Cited.
Concordance among gene-expression-based predictors for breast cancer.
Cheng Fan, Daniel S Oh, +5 authors, Charles M Perou.
N Engl J Med, 2006 Aug 11; 355(6). PMID: 16899776
Highly Cited.
Serine protease inhibitor Kazal type 1 promotes proliferation of pancreatic cancer cells through the epidermal growth factor receptor.
Nobuyuki Ozaki, Masaki Ohmuraya, +6 authors, Ken-Ichi Yamamura.
Mol Cancer Res, 2009 Sep 10; 7(9). PMID: 19737965
Therapeutic targeting of SPINK1-positive prostate cancer.
Bushra Ateeq, Scott A Tomlins, +9 authors, Arul M Chinnaiyan.
Sci Transl Med, 2011 Mar 04; 3(72). PMID: 21368222    Free PMC article.
TRARESA: a tissue microarray-based hospital system for biomarker validation and discovery.
Kakoli Das, Mohd Feroz Mohd Omar, +9 authors, Manuel Salto-Tellez.
Pathology, 2008 Jul 08; 40(5). PMID: 18604728
GAS6 mediates adhesion of cells expressing the receptor tyrosine kinase Axl.
P McCloskey, Y W Fridell, +4 authors, E T Liu.
J Biol Chem, 1997 Sep 12; 272(37). PMID: 9287338
The 76-gene signature defines high-risk patients that benefit from adjuvant tamoxifen therapy.
Yi Zhang, Anieta M Sieuwerts, +17 authors, John A Foekens.
Breast Cancer Res Treat, 2008 Sep 30; 116(2). PMID: 18821012
Adjusting batch effects in microarray expression data using empirical Bayes methods.
W Evan Johnson, Cheng Li, Ariel Rabinovic.
Biostatistics, 2006 Apr 25; 8(1). PMID: 16632515
Highly Cited.
The SPINK1 N34S variant is associated with acute pancreatitis.
Anil Bagul, Sunil Pushpakom, +2 authors, Ajith Siriwardena.
Eur J Gastroenterol Hepatol, 2009 Apr 17; 21(4). PMID: 19369834
Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer.
Soonmyung Paik, Gong Tang, +11 authors, Norman Wolmark.
J Clin Oncol, 2006 May 25; 24(23). PMID: 16720680
Highly Cited.
High expression of tumour-associated trypsin inhibitor correlates with liver metastasis and poor prognosis in colorectal cancer.
A Gaber, M Johansson, +6 authors, H Birgisson.
Br J Cancer, 2009 Apr 23; 100(10). PMID: 19384300    Free PMC article.
Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer.
Yixin Wang, Jan G M Klijn, +11 authors, John A Foekens.
Lancet, 2005 Feb 22; 365(9460). PMID: 15721472
Highly Cited.
Definition of clinically distinct molecular subtypes in estrogen receptor-positive breast carcinomas through genomic grade.
Sherene Loi, Benjamin Haibe-Kains, +14 authors, Christos Sotiriou.
J Clin Oncol, 2007 Apr 03; 25(10). PMID: 17401012
Highly Cited.
Biochemistry and clinical role of trypsinogens and pancreatic secretory trypsin inhibitor.
Annukka Paju, Ulf-Håkan Stenman.
Crit Rev Clin Lab Sci, 2006 Mar 07; 43(2). PMID: 16517420
The role of SPINK1 in ETS rearrangement-negative prostate cancers.
Scott A Tomlins, Daniel R Rhodes, +29 authors, Arul M Chinnaiyan.
Cancer Cell, 2008 Jun 10; 13(6). PMID: 18538735    Free PMC article.
Highly Cited.
Evaluation of urine tumor-associated trypsin inhibitor, CYFRA 21-1, and urinary bladder cancer antigen for detection of high-grade bladder carcinoma.
Ioannis Gkialas, Georgios Papadopoulos, +4 authors, Michael Lykourinas.
Urology, 2008 Jun 03; 72(5). PMID: 18514770
Genes that mediate breast cancer metastasis to lung.
Andy J Minn, Gaorav P Gupta, +7 authors, Joan Massagué.
Nature, 2005 Jul 29; 436(7050). PMID: 16049480    Free PMC article.
Highly Cited.
A gene-expression signature as a predictor of survival in breast cancer.
Marc J van de Vijver, Yudong D He, +18 authors, René Bernards.
N Engl J Med, 2002 Dec 20; 347(25). PMID: 12490681
Highly Cited.
Genetic reclassification of histologic grade delineates new clinical subtypes of breast cancer.
Anna V Ivshina, Joshy George, +12 authors, Lance D Miller.
Cancer Res, 2006 Nov 03; 66(21). PMID: 17079448
Highly Cited.
Pancreatic secretory trypsin inhibitor is a major motogenic and protective factor in human breast milk.
Tania Marchbank, Gillian Weaver, Marit Nilsen-Hamilton, Raymond J Playford.
Am J Physiol Gastrointest Liver Physiol, 2009 Jan 17; 296(4). PMID: 19147803
JMJD6 is a driver of cellular proliferation and motility and a marker of poor prognosis in breast cancer.
Yi Fang Lee, Lance David Miller, +6 authors, Kartiki V Desai.
Breast Cancer Res, 2012 May 25; 14(3). PMID: 22621393    Free PMC article.
Global gene expression profiling reveals SPINK1 as a potential hepatocellular carcinoma marker.
Aileen Marshall, Margus Lukk, +3 authors, Duncan T Odom.
PLoS One, 2013 Mar 26; 8(3). PMID: 23527199    Free PMC article.
JMJD6 promotes colon carcinogenesis through negative regulation of p53 by hydroxylation.
Feng Wang, Lin He, +13 authors, Yongfeng Shang.
PLoS Biol, 2014 Mar 29; 12(3). PMID: 24667498    Free PMC article.
Clinical evaluation of a multiple-gene sequencing panel for hereditary cancer risk assessment.
Allison W Kurian, Emily E Hare, +9 authors, James M Ford.
J Clin Oncol, 2014 Apr 16; 32(19). PMID: 24733792    Free PMC article.
Highly Cited.
Systems consequences of amplicon formation in human breast cancer.
Koichiro Inaki, Francesca Menghi, +16 authors, Edison T Liu.
Genome Res, 2014 Sep 05; 24(10). PMID: 25186909    Free PMC article.
SPINK1 Promoter Variants Are Associated with Prostate Cancer Predisposing Alterations in Benign Prostatic Hyperplasia Patients.
Danyelle Winchester, Luisel Ricks-Santi, +6 authors, Yasmine M Kanaan.
Anticancer Res, 2015 Jul 01; 35(7). PMID: 26124326    Free PMC article.
SPINK1 promotes colorectal cancer progression by downregulating Metallothioneins expression.
R Tiwari, S K Pandey, +5 authors, B Ateeq.
Oncogenesis, 2015 Aug 11; 4. PMID: 26258891    Free PMC article.
Gene expression and pathway analysis of human hepatocellular carcinoma cells treated with cadmium.
Laura Cartularo, Freda Laulicht, +3 authors, Max Costa.
Toxicol Appl Pharmacol, 2015 Sep 01; 288(3). PMID: 26314618    Free PMC article.
Serine protease inhibitor Kazal type 1 (SPINK1) drives proliferation and anoikis resistance in a subset of ovarian cancers.
Christine Mehner, Ann L Oberg, +13 authors, Evette S Radisky.
Oncotarget, 2015 Oct 06; 6(34). PMID: 26437224    Free PMC article.
Prognostic value of ERG, PTEN, CRISP3 and SPINK1 in predicting biochemical recurrence in prostate cancer.
Byeong-Joo Noh, Ji-Youn Sung, +2 authors, Yong-Koo Park.
Oncol Lett, 2016 Jun 11; 11(6). PMID: 27284364    Free PMC article.
Transposon mutagenesis identifies genes that cooperate with mutant Pten in breast cancer progression.
Roberto Rangel, Song-Choon Lee, +12 authors, Neal G Copeland.
Proc Natl Acad Sci U S A, 2016 Nov 17; 113(48). PMID: 27849608    Free PMC article.
Is There a Role for Genetic Information in Risk Assessment and Decision Making in Prostate Cancer?
Mohamadreza Nowroozi, Mohsen Ayati, +7 authors, Alireza Ghadian.
Nephrourol Mon, 2016 Dec 10; 8(6). PMID: 27933279    Free PMC article.
Identification of genes associated with matrix metalloproteinases in invasive lung adenocarcinoma.
Weiqing Li, Xugang Zhang, +3 authors, Bo Wei.
Oncol Lett, 2018 Jun 22; 16(1). PMID: 29928392    Free PMC article.
The Role of Serine Peptidase Inhibitor Kazal Type 13 (SPINK13) as a Clinicopathological and Prognostic Biomarker in Patients with Clear Cell Renal Cell Carcinoma.
Wen-Hao Xu, Shen-Nan Shi, +7 authors, Ding-Wei Ye.
Med Sci Monit, 2019 Dec 12; 25. PMID: 31825950    Free PMC article.
Downregulated SPINK4 is associated with poor survival in colorectal cancer.
Xiaojie Wang, Qian Yu, +8 authors, Pan Chi.
BMC Cancer, 2020 Jan 01; 19(1). PMID: 31888570    Free PMC article.
Epigenetic Silencing of miRNA-338-5p and miRNA-421 Drives SPINK1-Positive Prostate Cancer.
Vipul Bhatia, Anjali Yadav, +7 authors, Bushra Ateeq.
Clin Cancer Res, 2018 Dec 28; 25(9). PMID: 30587549    Free PMC article.
Bad Tumors Made Worse: SPINK1.
Christine Mehner, Evette S Radisky.
Front Cell Dev Biol, 2019 Feb 20; 7. PMID: 30778387    Free PMC article.
Targeting an autocrine IL-6-SPINK1 signaling axis to suppress metastatic spread in ovarian clear cell carcinoma.
Christine Mehner, Erin Miller, +4 authors, Evette S Radisky.
Oncogene, 2020 Sep 16; 39(42). PMID: 32929152    Free PMC article.
Hepatitis B Virus X Protein-Induced Serine Protease Inhibitor Kazal Type 1 Is Associated with the Progression of HBV-Related Diseases.
Chengliang Zhu, Huan Han, +4 authors, Xinghui Liu.
Biomed Res Int, 2019 Jun 27; 2019. PMID: 31240230    Free PMC article.